Bell Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $959 | Hold |
107
| – | – | ﹤0.01% | 1595 |
|
|
2025
Q1 | $803 | Hold |
107
| – | – | ﹤0.01% | 1624 |
|
|
2024
Q4 | $805 | Hold |
107
| – | – | ﹤0.01% | 1645 |
|
|
2024
Q3 | $814 | Hold |
107
| – | – | ﹤0.01% | 1657 |
|
|
2024
Q2 | $662 | Buy |
+107
| New | +$662 | ﹤0.01% | 1722 |
|
|
2023
Q4 | – | Sell |
-132
| Closed | -$935 | – | 1920 |
|
|
2023
Q3 | $935 | Buy |
132
+9
| +7% | +$64 | ﹤0.01% | 1597 |
|
|
2023
Q2 | $866 | Hold |
123
| – | – | ﹤0.01% | 1634 |
|
|
2023
Q1 | $1.03K | Buy |
123
+2
| +2% | +$17 | ﹤0.01% | 1565 |
|
|
2022
Q4 | $1.39K | Hold |
121
| – | – | ﹤0.01% | 1457 |
|
|
2022
Q3 | $2K | Hold |
121
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q2 | $1K | Buy |
+121
| New | +$1K | ﹤0.01% | 1339 |
|